198 related articles for article (PubMed ID: 12820402)
1. Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells.
Ishiwata N; Inase N; Fujie T; Tamaoka M; Yoshizawa Y
Anticancer Res; 2003; 23(2B):1405-9. PubMed ID: 12820402
[TBL] [Abstract][Full Text] [Related]
2. Calretinin promoter for suicide gene expression in malignant mesothelioma.
Inase N; Miyake S; Yoshizawa Y
Anticancer Res; 2001; 21(2A):1111-4. PubMed ID: 11396148
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
4. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
[TBL] [Abstract][Full Text] [Related]
5. Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.
Tanaka M; Inase N; Miyake S; Yoshizawa Y
Anticancer Res; 2001; 21(1A):291-4. PubMed ID: 11299750
[TBL] [Abstract][Full Text] [Related]
6. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
7. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
Zhang Y; Huang SZ; Zeng YT
Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
[TBL] [Abstract][Full Text] [Related]
8. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
[TBL] [Abstract][Full Text] [Related]
9. MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
Schoensiegel F; Paschen A; Sieger S; Eskerski H; Mier W; Rothfels H; Kleinschmidt J; Schadendorf D; Haberkorn U
Cancer Gene Ther; 2004 Jun; 11(6):408-18. PubMed ID: 15118759
[TBL] [Abstract][Full Text] [Related]
10. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
11. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
12. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
13. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
14. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter].
Song Y; Kong BH; Liu PS; Ma DX; Qu X; Jiang S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):438-42. PubMed ID: 12974091
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter.
Morimoto E; Inase N; Mlyake S; Yoshizawa Y
Anticancer Res; 2001; 21(1A):329-31. PubMed ID: 11299758
[TBL] [Abstract][Full Text] [Related]
17. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
18. Effect of the rabbit alphas1-casein gene distal enhancer on the expression of a reporter gene in vitro and in vivo.
Pantano T; Jolivet G; Prince S; Menck-Le Bourhis C; Maeder C; Viglietta C; Rival S; Houdebine LM
Biochem Biophys Res Commun; 2002 Jan; 290(1):53-61. PubMed ID: 11779132
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy.
Berlinghoff S; Veldwijk MR; Laufs S; Maser HP; Jauch A; Wenz F; Jens Zeller W; Fruehauf S
Lung Cancer; 2004 Nov; 46(2):179-86. PubMed ID: 15474666
[TBL] [Abstract][Full Text] [Related]
20. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
Liu XP; Li BJ; Zhang C
Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]